mAbHits AbvantageTM

The mAbHits AbvantageTM module of the Rational Antibody Discovery platform is an immunoengineering system that manipulates the immune response to control the production of antibodies against defined optimal yet elusive epitopes on a disease-associated protein. AbvantageTM induces a specific and elevated immune response, generating affinity maturation of antibodies against optimal epitopes.

Classical Approaches vs. Rational Antibody Discovery

Missing the Mark

Classical approaches to antibody discovery often led to the majority of antibodies produced missing the optimal epitopes.

AbvantageTM mice

Abvantage mice are transgenic mice designed to produce an immune response that results in majority of the resulting antibodies hitting the desired epitopes.

AbvantageTM mouse

Hummingbird Bioscience’s Rational Antibody Discovery platform conditionally modifies B cells in vivo during immunization to direct optimal antibody responses to epitopes of interest determined with AI-aided algorithms. Our proprietary genetically engineered mice yield robust epitope-focused B cell responses that enable accelerated discovery of high affinity, epitope-specific antibodies.

Speak with us

Our proprietary platform and technologies have tackled challenging disease targets. We have successfully discovered highly differentiated antibodies that can be applied to different therapeutic modalities including antibody-drug conjugates, T-cell engagers and antagonists. Our technology unlocks opportunities for the development of a new generation of antibody-based therapeutics with potential to be best-in-class.

Contact bd@hummingbirdbio.com if you would like to learn more about our platform.